90
True
United States
The text questions whether Biden or Trump lowered insulin prices.
While both Biden and Trump advanced policies to reduce insulin costs, the $35 copay cap for Medicare was influenced by pharmaceutical companies. Trump initiated the Part D Senior Savings Model, effectively setting insulin at $35, which continued under Biden's policies.
Individual Claims
90
True
Politics
Either Biden or Trump lowered insulin prices.
The $35 insulin copay cap was part of Trump's initiative, continued under Biden. Both played roles, but pharmaceutical companies also influenced this cap.
